Leung King Fai resigned as an independent director of Biostar Pharmaceuticals Inc., effective Dec. 12.
King Fai resigned because his director's fee from Jan. 1, 2014, to present had not been paid.
Discover more about S&P Global’s offerings
Biostar Pharmaceuticals director resigns
Insight Weekly: SVB fallout limited; US rents up; renewable natural gas investments flow in
A Cloud Migration Plan for Corporations featuring Snowflake®
Investor Activism Campaigns Hit Record High in 2022
Essential IR Insights Newsletter - February 2023
Leung King Fai resigned as an independent director of Biostar Pharmaceuticals Inc., effective Dec. 12.
King Fai resigned because his director's fee from Jan. 1, 2014, to present had not been paid.